Article
Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.
Antimicrobial agents and chemotherapy - 1 Feb 2005
Rafii Fatemeh, Park Miseon, Novak John S
Abstract excerpt
To compare mutations in the DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE) genes of Clostridium perfringens, which are associated with in vitro exposure to fluoroquinolones, resistant mutants were selected from eight strains by serial passage in the presence of increasing concentrations of norfloxacin, ciprofloxacin, gatifloxacin, or trovafloxacin. The nucleotide sequences of the entire gyrA,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
